webinar register page

Webinar banner
Redeploying Beta-Lactam Antibiotics Against Methicillin-Resistant Staphylococcus aureus (MRSA)
Learning Objectives:
• Understand how beta-lactams bolster the host immune response to S. aureus infection
• Understand the mechanisms responsible for beta-lactam synergy against MRSA
• Review clinical data regarding beta-lactam combination therapy for invasive MRSA infections

Aug 12, 2020 01:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

Speakers

Sarah Jorgensen
Sarah joined Mount Sinai Hospital’s Antimicrobial Stewardship Team as their Stewardship Pharmacist in September 2019. She is originally from the West Coast of Canada, where she completed Bachelor of Science degrees in Math and Pharmacy at UBC. Sarah worked as a clinical pharmacist in a community hospital near Victoria for several years before going on to complete her PharmD at the University of Florida. She then completed a PGY1 Pharmacy Practice residency at Tallahassee Memorial Hospital and a PGY2 Infectious Disease residency at the University of Southern California, an Infectious Diseases Pharmacotherapy Research Fellowship at Wayne State University, and a Master of Public Health, also at Wayne State University. Sarah’s research has focused on novel treatment strategies for invasive MRSA infections, antimicrobials for multidrug-resistant gram-negative infections, and antimicrobial pharmacokinetic/pharmacodynamics.